跳至主要内容
临床试验/NL-OMON41060
NL-OMON41060已完成2 期

Effect of Gelofusine on 111In-DTPA-AHX-Lys40-Exendin 4 uptake in the kidney - Effect of Gelofusine on GLP1-receptor imaging

niversitair Medisch Centrum Sint Radboud0 个研究点目标入组 11 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
11

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • * ><= 18 years
  • * <<= 60 years
  • * Normal renal function (creatinine clearance > 90mL/min according to the formula of Cockroft and Gault)
  • * Normal glucose regulation (HbA1c 53 /mol (7%))
  • * BMI 17>30

排除标准

  • * Use of any medication affecting renal function
  • * Known hypersensitivity to one of the substances used
  • * Hypertension
  • * Hypervolaemia
  • * Heart failure
  • * Pregnancy or the wish to become pregnant within 3 months after participation of the study.
  • * Lactation
  • * History of anaphylaxis
  • * Liver disease defined as aspartate aminotransferase or alanine aminotransferase level more than 3 times the upper limit of normal range (45U/L)

研究者

发起方
niversitair Medisch Centrum Sint Radboud

相似试验

进行中(未招募)
不适用
Determination of the effect of Gelofusine on the kidney uptake of a radioactive tracer molecule used for imaging of insulin producing beta-cells in the pancreasThe aim of this study is to reduce the kidney uptake during 111In-DTPA- exendin4 imaging, a promising and valuable tool for beta-cell mass imaging and quantification, which can be applied in patients with e.g. diabetes.MedDRA version: 17.1Level: HLGTClassification code 10018424Term: Glucose metabolism disorders (incl diabetes mellitus)System Organ Class: 10014698 - Endocrine disordersMedDRA version: 17.1Level: HLTClassification code 10012602Term: Diabetes mellitus (incl subtypes)System Organ Class: 10014698 - Endocrine disordersMedDRA version: 17.1Level: PTClassification code 10012601Term: Diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersMedDRA version: 17.1Level: PTClassification code 10067584Term: Type 1 diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disorders
EUCTR2014-003006-33-NLRadboud University Medical Center
已完成
1 期
Effect of Gelofusine on GLP1-receptor ImagingDiabetes Mellitus, Non-Insulin-DependentDiabetes Mellitus
NCT02541734Radboud University Medical Center12
进行中(未招募)
1 期
Effect of the plasma substitutes Gelofusine and Hydroxyethyl Starch 130/0.4 combined with lactated ringer's solution on the coagulation system - Effect of plasma substitutes on the coagulation system
EUCTR2011-000156-42-NLAmphia Hospital60
已完成
4 期
Effect of the plasma substitutes Gelofusine and Hydroxyethyl Starch 130/0.4 combined with lactated ringer's solution on the coagulation systemstollingssysteem na gebruik van de hartlongmachine bij open-hart chirurgiecoagulationplasma substitutestromboelastometry
NL-OMON36390Amphia Ziekenhuis60
尚未招募
3 期
Impact of saffron tablets on Doxorubicin-induced cardiotoxicityCardiomyopathy.Cardiomyopathy due to drug and external agentI42.7
IRCT20120703010178N26Shahid Beheshti University of Medical Sciences188
Effect of Gelofusine on 111In-DTPA-AHX-Lys40-Exendin... | 临床试验